Lioresal in Huntington's disease.
D000613:Aminobutyrates / Q000627:therapeutic use*; D001418:Baclofen / Q000627:therapeutic use*; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004341:Drug Evaluation; D005684:Gait; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000503:physiopathology; D011388:Prolactin / Q000097:blood; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D000613:Aminobutyrates; D005680:gamma-Aminobutyric Acid; D011388:Prolactin; D013006:Growth Hormone; D003620:Dantrolene; D001418:Baclofen; D003975:Diazepam